Regeneron works on UK, S.African Covid variants, says company | Malay Mail

Business News News

Regeneron works on UK, S.African Covid variants, says company | Malay Mail
Business Business Latest News,Business Business Headlines

WASHINGTON, Jan 28 — Regeneron’s synthetic antibody treatment remains effective against the British and South African variants of the novel coronavirus, the US biotechnology company announced yesterday. The therapy used on ex-president Donald Trump has had emergency approval since November for...

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York September 17, 2020. — Reuters pic

REGEN-COV — featuring potent neutralizing antibodies called imdevimab and casirivimab — remained effective against both variants, the company said in a statement, although casirivimab’s potency against the South African variant was “reduced.” “These data show the continued ability of REGEN-COV to neutralize emerging strains, further validating our multi-antibody cocktail approach to infectious diseases,” said George Yancopoulos, Regeneron’s president and chief scientific officer.

 

Business Business Latest News, Business Business Headlines



Render Time: 2025-01-10 09:24:54